Effect of oral curcumin on reducing the recurrence of nasal polyposis

Evaluation of the effect of oral curcumin on reducing the recurrence of nasal polyposis in patients undergoing endoscopic sinus surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151123025202N24

Enrollment

Registered

2022-10-24

Start date

2022-11-22

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasal polyposis. Nasal polyp

Interventions

Intervention 1: Intervention group: Patients with chronic sinusitis resistant to treatment after endoscopic sinus surgery, in addition to routine post-treatment care and follow-up, take a 500 mg curcu

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with chronic sinusitis resistant to drug treatment Having nasal polyps

Exclusion criteria

Exclusion criteria: Having an allergy to turmeric Immunodeficiency problem Suffering from systemic diseases such as diabetes, renal failure, malignancies, cystic fibrosis and granulomatous diseases.

Design outcomes

Primary

Measure	Time frame
Relapse of polype. Timepoint: Before treatment, 1 month, 4 months and 6 months after treatment. Method of measurement: Nasal endoscopy.	—

Secondary

Measure	Time frame
Treatment Complication. Timepoint: 1, 2 and 6 months after treatment. Method of measurement: Visual Analogue Score (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Moradi

Medical Schol

a.moradi@umsha.ac.ir+98 81 3838 0557

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026